BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33314233)

  • 1. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia.
    Lubel JS; Roberts SK; Howell J; Ward J; Shackel NA
    Intern Med J; 2021 Feb; 51(2):181-188. PubMed ID: 33631853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region.
    Waked I; Alsammany S; Tirmazy SH; Rasul K; Bani-Issa J; Abdel-Razek W; Omar A; Shafik A; Eid S; Abdelaal A; Hosni A; Esmat G
    Liver Int; 2023 Oct; 43(10):2062-2077. PubMed ID: 37553777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide.
    Rich NE
    Surg Oncol Clin N Am; 2024 Jan; 33(1):1-12. PubMed ID: 37945136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic management of hepatocellular carcinoma.
    Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
    World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
    González Huezo MS; Sánchez Ávila JF; ; ; ; ; ;
    Rev Gastroenterol Mex; 2014; 79(4):250-62. PubMed ID: 25487133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review.
    Seth I; Siu A; Hewitt L; Budak U; Farah B; Jaber M
    J Gastrointest Cancer; 2024 Mar; 55(1):318-331. PubMed ID: 37480425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
    Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
    World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
    Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
    Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
    Pocha C; Kolly P; Dufour JF
    Semin Liver Dis; 2015 Aug; 35(3):304-17. PubMed ID: 26378646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and Management of Hepatocellular Carcinoma.
    Kulik L; El-Serag HB
    Gastroenterology; 2019 Jan; 156(2):477-491.e1. PubMed ID: 30367835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
    Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and management of hepatocellular carcinoma.
    Yang JD; Roberts LR
    Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatocellular carcinoma: SASL expert opinion statement.
    Goossens N; Toso C; Heim MH
    Swiss Med Wkly; 2020 Jul; 150():w20296. PubMed ID: 32789822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.